Dr. Miriam D Velez, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: Ave Agustin Ramos Calero, Bzn 737, Isabela, PR 00662 Phone: 787-830-2705 Fax: 787-830-0465 |
Joselito Romero Lopez, MD Family Medicine - Adult Medicine Medicare: Medicare Enrolled Practice Location: 8494 Ave Jobos, Isabela, PR 00662 Phone: 787-872-9223 Fax: 787-872-9223 |
Dr. Marco Antonio Corchado Barreto, M.D. Family Medicine - Adult Medicine Medicare: Accepting Medicare Assignments Practice Location: 7260 Ave Agustin Ramos Calero, Isabela, PR 00662 Phone: 787-872-8313 Fax: 787-872-8313 |
News Archive
Portable media devices, such as cell phones and tablets, are ever present in children's lives, and the majority of children and adolescents have devices present where they sleep.
EpiCept Corporation today provided an update on new clinical developments and other initiatives related to CepleneĀ® (histamine dihydrochloride), the Company's therapy approved in the European Union for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first remission.
Researchers at King's College London have found no significant link between eating the evening meal after 8pm and excess weight in children, according to a paper published this month in the British Journal of Nutrition.
Ranbaxy Laboratories Limited announced today that the Company has received approval from the U.S. Food and Drug Administration to manufacture and market Fenofibrate Capsules USP, 43 mg and 130 mg. The Office of Generic Drugs, U.S. Food and Drug Administration, has determined the Ranbaxy formulations to be bioequivalent and have the same therapeutic effect as that of the reference listed drug Antara Capsules, 43 and 130 mg, respectively, of Lupin Atlantis.
Civitas Therapeutics, Inc., a privately-held pharmaceutical company developing transformative therapeutics using the ARCUS respiratory delivery platform, announced today that the Company will make its first public presentation at the Sixth Annual Parkinson's Disease Therapeutics Conference, sponsored by The Michael J. Fox Foundation for Parkinson's Research, to be held on October 24th in New York City.
› Verified 2 days ago